Respiratory News and Research

RSS

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

In the state of Jonglei in South Sudan, civilians continue to bear the brunt of inter-communal fighting. Wounded patients are still arriving at the Médecins Sans Frontières hospital in Pibor, three weeks after the violent attack on the town and outlying villages in Pibor County. Many were injured in the bush, where thousands have remained, afraid to come out of hiding. Médecins Sans Frontières medical teams are now treating serious wound infections, some several weeks old. Since re-launching emergency medical activities in Pibor on 7 January, Médecins Sans Frontières has treated 47 patients with gunshot wounds – 16 women and 8 children. A further 43 patients have so far been treated for stab wounds, beatings or wounds sustained while fleeing in the bush.

24 Jan 2012

Elderly patients more likely to develop respiratory or gastrointestinal infections after ED visits

Elderly patients who have visited an emergency department (ED) are three times more likely to develop respiratory or gastrointestinal infections in the week following their return to a long-term care facility, such as a Centre d'H-bergement de Soins de Longue Dur-e.

24 Jan 2012

Ikaria receives FDA orphan drug designation for use of iNO in PAH

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the use of inhaled nitric oxide (iNO) with the INOpulse DS drug-delivery system as a combination product for pulmonary arterial hypertension.

23 Jan 2012

RBC storage duration not associated with transfusion-related pulmonary complications

There is no difference in early measures of pulmonary function, immunologic status or coagulation status after fresh versus standard issue single-unit red blood cell (RBC) transfusion, according to a new study from the Mayo Clinic.

21 Jan 2012

Awake ECMO may be an effective bridging strategy for lung transplantation candidates

Extracorporeal membrane oxygenation (ECMO) support in awake, non-intubated patients may be an effective strategy for bridging patients to lung transplantation, according to a new study from Germany.

21 Jan 2012

Accelerated growth may increase risk of asthma symptoms in young children

Accelerated growth in the first three months of life, but not fetal growth, is associated with an increased risk of asthma symptoms in young children, according to a new study from The Generation R Study Group at Erasmus Medical Center in the Netherlands.

20 Jan 2012

Study: Up to 30% of patients hospitalized after a stroke develop delirium

Up to 30 per cent of patients hospitalized after a stroke develop delirium, according to a new study from St. Michael's Hospital.

20 Jan 2012

Children with neurologic impairment account for increasing hospital resources

Because of care advances, more infants and children with previously lethal health problems are surviving. Many, however, are left with lifelong neurologic impairment. A Children's Hospital Boston study of more than 25 million pediatric hospitalizations in the U.S. now shows that neurologically impaired children, though still a relatively small part of the overall population, account for increasing hospital resources, particularly within children's hospitals.

18 Jan 2012

Health influence of combustion conditions in wood-burning stoves

Wood-burning stoves are a popular source of heating in many countries. However in recent years there has been much debate about the potential negative health effects associated with wood smoke. A Norwegian researcher has studied the influence of combustion conditions on the emissions and their health effects.

18 Jan 2012

BJALCF receives $1 million in grants for 2012 Lung Cancer Research

Just two months shy of marking its 7-year anniversary, BJALCF announced today that it has awarded over $1 million in grants for 2012 Lung Cancer Research. BJALCF has made a promise to the Lung Cancer Community to fund only immediate results-oriented projects or programs promising to catalyze progress through early detection, genetic testing, drug discovery and patient-focused outcomes.

17 Jan 2012

Stallergenes chooses Magic Software's iBOLT integration platform

Magic Software Enterprises Ltd., a global provider of mobile and cloud-enabled application and business integration platforms, announced today that Stallergenes, a biopharmaceutical company and world leader in the treatment of severe allergic respiratory illnesses, has chosen Magic Software's iBOLT integration platform to integrate its various purchasing systems with its SAP ERP.

17 Jan 2012

Occasional marijuana use does not affect lung function: Study

A new study published in the Journal of the American Medical Association has shown that an occasional drag on marijuana does not appear to have long-term adverse effects on lung function.

11 Jan 2012

Intestinal worm infections may not be bad

Intestinal worm infections may not be all bad, according to a new study by William C. Gause, PhD, and colleagues at UMDNJ- New Jersey Medical School. The researchers have found cytokines that help oust intestinal worm infections in mice also soothe associated lung injury and inflammation.

11 Jan 2012

Tobacco more harmful to lungs than marijuana

A large-scale national study suggests low to moderate use of marijuana is less harmful to users' lungs than exposure to tobacco, even though the two substances contain many of the same components. This comprehensive study, led by UCSF and University of Alabama at Birmingham, collected data from more than 5,000 U.S. adults for more than 20 years.

11 Jan 2012

Study examines impact of maternal obesity on inflammatory responses

A number of different immunological mechanisms ensure the successful establishment and maintenance of pregnancy. Imbalance in these mechanisms is associated with adverse pregnancy outcomes.

11 Jan 2012

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

Pulmonx SARL today announced that its European notified body has granted CE approval for expanded labeling of its Zephyr endobronchial valve.

11 Jan 2012

Children delivered by caesarean section at slightly elevated risk of asthma: MoBa study

A new study supports previous findings that children delivered by caesarean section have an increased risk of developing asthma.

11 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Positive topline results from Civitas' CVT-301 Phase 1 trial on PD

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS(TM) respiratory delivery platform, announced today positive topline results from a Phase 1 clinical trial for CVT-301, an inhaled formulation of levodopa (L-dopa) for the rapid relief from motor fluctuations associated with Parkinson's disease.

7 Jan 2012

Non-eosinophilic disease more prevalent in patients with mild-to-moderate asthma

A large percentage of patients with mild-to-moderate asthma have persistently non-eosinophilic disease which may not respond to currently available anti-inflammatory treatments, according to a new study.

6 Jan 2012